Citations 15

Chimeric Antigen Receptor Engineering of Mesenchymal Stromal Cells (CAR-MSC) Enhance Immunosuppression and Outcomes in Graft Versus Host Disease (GvHD) Preclinical Models

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1579-1580

10.1182/blood-2022-158872

CD19 Antigen Occupancy on Cancer Cells with the CD19 Monoclonal Antibody Tafasitamab Improves the Activation, Antitumor Efficacy, and Safety Profile of CART19 Cell Therapy

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2362-2364

10.1182/blood-2022-158273

Immunosuppressive Monocyte Modulation of CAR T Cell Functions and Impact on Response to CART19

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10263-10264

10.1182/blood-2022-164706

Targeting a Dominant Negative Splice Variant of TRAIL to Enhance CART Cell Functions

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 632-633

10.1182/blood-2022-163677

Differential Susceptibility to Senescence in CART Cells Based on Co-Stimulatory Signaling

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8600-8601

10.1182/blood-2022-163446